Infectious Disease Clinical Bootcamp for APPs
IDSA's Infectious Disease Clinical Bootcamp was created specifically for advanced practice providers. This four-hour workshop provides an overview of foundational and progressive topics relevant to APPs entering and currently practicing in the ID field. Hear expert speakers discuss clinical updates on orthopedic ID and infective endocarditis, antibiotics and more.
Target Audience
- Nurse Practitioners (NPs)
- Physician Assistants (PAs)
- Clinical Nurse Specialists (CNSs)
- Others in APP roles interested in ID Topics
Learning Objectives
At the conclusion of this course, participants will be able to:
- describe general management of long bone osteomyelitis, prosthetic joint and vertebral infections;
- investigate a systematic approach in the initial evaluation and diagnosis of infectious diseases;
- explain successful opat models and describe multi-disciplinary roles within the opat team.
All relevant financial relationships have been mitigated.
Workshop Moderator(s)
Leah Yoke, PA-C, MCHS
Physician Assistant
University of Washington; Fred Hutch Cancer Research Center
Seattle, WA, United States
No financial relationships to disclose
Courtney Russ-Friedman, MSN, FNP-BC
Advanced Practice Provider
Wake Forest Baptist Health
Winston-Salem, NC, United States
No financial relationships to disclose
Faculty
Luke Strnad, MD (he/him/his)
Associate Professor of Medicine
Oregon Health and Science University and Portland State University School of Public Health
Portland, Oregon, United States
No financial relationships to disclose
Vera Luther, MD (she/her/hers)
Professor of Medicine
Department of Medicine, Section on Infectious Diseases
Wake Forest University School of Medicine
Winston Salem, NC, United States
No financial relationships to disclose
Christopher Ohl, MD
Professor of Medicine
Infectious Diseases
Wake Forest University School of Medicine
Winston Salem, NC, United States
No financial relationships to disclose
Paul Pottinger, MD (he/him/his)
Professor of Medicine
Infectious Diseases
University of Washington School of Medicine
Seattle, WA, United States
No financial relationships to disclose
Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP (she/her/hers)
Clinical Pharmacy Specialist, Ambulatory/Infectious Diseases
Beth Israel Deaconess Medical Center
Boston, MA, United States
ASHP: Honoraria (Ongoing); BD Diagnostics: Advisor/Consultant (Terminated, December 31, 2023); Cidara Therapeutics Inc.: Advisor/Consultant (Terminated, December 31, 2023); GSK: Advisor/Consultant (Ongoing); IDSA: Associate Editor (Ongoing); Merck Sharp & Dohme Corp: Grant/Research Support (Ongoing)
Alison Beieler, PA-C (she/her/hers)
Physician Assistant
Harborview Medical Center
Seattle, Washington, United States
No financial relationships to disclose
Accreditation Statement
In support of improving patient care, IDSA is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME Credit Designation Statement
IDSA designates this enduring material for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physician participation information will be shared with ABIM through ACCME PARS.